JWCA acts as an exchange agent for wright medical group on its $395 million convertible bond exchange and new issuance
May 2016 | read press release
Transaction Background
JWCA was hired by Wright Medical Group to advise on its capital strucure, then execute a capital raise in a smart, efficient manner
Evaluated refinancing options with the Wright team, including comparative analytics for:
Publicly marketed new issuance
Private wall-crossed convertible exchange
Credit facility
Designed the private wall-cross and exchange strategy to avoid stock price risk, focus on outright long-only investors, and achieve attractive terms:
Included optimization of call spread terms including pricing and company-friendly documentatio
Assisted the team with documentation, accounting, and tax review
Provided advice, support and analysis during the execution
Results
The Company extended maturity on $99mm of debt and raised $294mm of new capital:
Upsized the transaction from a base deal size of $250mm to $395mm, thereby adding meaningful cash to the Balance Sheet
Repurchased $54mm of existing 2.00% convertible due 2017 and $45mm of existing 2.00% convertible due 2020, thereby pushing out maturity on a sizable portion of their liability by 3+ years
Avoided stock price risk, as we executed on an overnight basis after the wall-cross
Wright achieved attractive call spread terms:
Increased effective conversion price from $24.67 on 2017 notes to $30.00
Negotiations produced meaningful savings for the Company